The following study demonstrated that Nrf2, a key factor in lipid metabolism and antioxidant response, had higher gene expression and DNA-binding activity in the NASH group than in controls. The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatohepatitis.